All posts by student

Neuroscience | Dickinson College

The neuroscience major provides students with rigorous, laboratory-based exposure to the fascinating multidisciplinary study of the brain. The program is ideal for students planning graduate or professional study in neuroscience, biology, chemistry, psychology, medicine and other related fields.

Neuroscience sits at the intersection of biology, chemistry and psychology. The term "neuroscience" was coined in the 1960s to name an interdisciplinary field that focused on both the normal and abnormal structure and function of the nervous system. Dickinson now offers students a major in neuroscience, in which Dickinson students will engage in an integrated curriculum in this very popular interdisciplinary field. The neuroscience major provides students with rigorous training in neuroscience and allied science disciplines, advanced opportunities for research, and integrated mentoring and advising of students.

The integrative nature of the two introductory neuroscience courses (Psychology 125 and Biology 124), placed both within psychology and biology, and also at the intersection of these two fields, demonstrates to the student the interconnectedness of these two sciences. Upper division courses allow the student to bring research skills to bear in the laboratory and to integrate skill and knowledge gained in the introductory courses. The elective requirements in the major allow the student to explore the many facets of neuroscience, and the student can then choose to focus on molecular or molar approaches to neuroscience; can choose to emphasize biology, chemistry or psychology within their neurosciences major; and can explore the ways other fieldssuch as anthropology, philosophy or sociologyintersect with neuroscience. Finally, a research experience allows the major to engage the world by bringing to bear learned knowledge and skills.

Read the original post:
Neuroscience | Dickinson College

The Neuroscience Training Summit

In the last few decades, there has been a revolution in the field of neuroscience that is changing the way we live, love, and work. For many, it's been difficult to keep up.

We created this summit to bring you up to date with the latest discoveries that have immediate application in your lifein a straightforward and practical way that does not require a background in neuroscience or previous study of the brain.

The Neuroscience Training Summit is your chance to learn directly from the world's leading experts about their groundbreaking discoveries and, most importantly, how you can start to apply this wisdom to your life right away.

These experts will share with you the details of their research AND provide you with practical, experiential exercises and tools that you can use in your personal and professional lives.

To go even deeper with your exploration of this incredible wealth of information, we're offering a special upgrade package that gives you lifetime access to the teaching sessions of each of our 20 presenters, plus much more.

Thanks for signing up. We look forward to being with you on The NeuroscienceTraining Summit.

Tami Simon Founder of Sounds True

Excerpt from:
The Neuroscience Training Summit

Judaism, neuroscience and the free will hypothesis (Part 2) – Jewish Journal (blog)

The Jewish assumption of free will is ancient and enduring. But what does modern neuroscience have to say?

The history of neuroscientists efforts to explore the free will phenomenon was reviewed in 2016 by philosopher and neuroethicist Andrea Lavazza in the journal Frontiers in Human Neuroscience. The setting for our current understanding was drawn a half century ago with the discovery by Hans Kornhuber and Luder Deecke of the Readiness Potential (RP), a measurement of increased bio-electric activity in the brain. The RP was measured by an electroencephalogram (EEG), a procedure in which electrodes were placed on a subjects scalp to allow for the recording of bio-electric activity. This activity was seen as an indication of preparation for a volitional act.

One question raised by the discovery of RP was whether an individual was conscious of an intention to act before RP appeared. In the early 1980s, Benjamin Libet, a son of Jewish immigrants from Ukraine who became a neuroscientist at the University of California-Davis, sought to answer that question. Libet and his team designed a relatively simple test. First, subjects were wired for an EEG. To record muscle contraction, electrodes were also placed on subjects fingers. Then the subjects were asked to do two things, spontaneously move their right finger or wrist, and, with the aid of a clock in front of them, report to researchers the time they thought they decided to do so.

What Libet found (Libet et al. 1983) was that conscious awareness of the decision to move a finger preceded the actual movement of the finger by 200 milliseconds (ms), but also that RP was evident 350 ms before such consciousness. While Libet recognized that his observations had profound implications for the nature of free will, for individual responsibility and guilt, his report appropriately contained several caveats. First, it noted (at 640) that the present evidence for the unconscious initiation of a voluntary act of course applies to one very limited form of such acts. Second (at 641), it allowed for the possibility that there could be a conscious veto that aborts the performance . . . (of) the self-initiated act under study here. Finally (at 641), it acknowledged that the possibilities for conscious initiation and control in situations that were not spontaneous or quickly performed.

Not surprisingly, and despite the caveats, some interpreted Libets experimental results as proof that ones actions are not freely made, but, rather, predetermined by unconscious neural activity. In the years following the publication of Libets report, other experimenters have not only replicated his work, with more sophisticated measuring devices, they have extended it.

For instance, experiments reported in 1999 by Patrick Haggard and Martin Eimer involved index fingers on both hands, and they calculated both RP and lateralized RP. Subsequently, scientists at the Max Plank Institute for Human Cognitive and Brain Sciences also utilized right and left index fingers, this time to press a button, and his subjects reported awareness of action not by observing a clock, but by identifying one of many letters streaming by. Brain activity was detected by using functional magnetic resonance imaging (fMRI) signals. In a 2008 publication in Nature authored by Chun Siong Soon and others, Soon et al. claimed that brain activity encoding a decision could be detected in the prefrontal and parietal cortex for up to ten seconds before the subject became aware.

Also not surprisingly, the assumptions in and the interpretations of results from these experiments drew criticism, beyond the obvious concern about mistaking correlation (of recorded brain activity) with causation (of a decision to act). And they continue to do so. After all, the average human brain contains billions and billions of nerve cells called neurons. We have recently learned the number of neurons is approximately 86 billion. Each neuron is connected to other neurons by perhaps thousands of synapses, junctions through which neuroactive molecules or electrical impulses travel. The total number of these synaptic connections exceeds 100 trillion. Moreover, while we once believed the brain to be fixed, now we know that is more plastic, and changes constantly.

Even if we were thoroughly familiar with all of these connections, and all of the electrical and chemical processes which operate (or not), and when and why they do (or do not), and also had a complete grasp of neuroplasticity, which understandings we do not currently possess, we clearly do not understand what has been called the Hard Problem, the nature of consciousness. If we do not understand that, then obviously we also do not understand the nature of sub-consciousness. So, what exactly, if anything, Libet and Soon were observing other than some sort of recordable activity is not apparent.

More narrow objections could be and were raised, as well, to the early tests. Florida State philosophy professor Alfred Mele suggested that because subjects might have different understandings of the awareness of the intention to move they were to report, the term was too ambiguous to measure to any degree of scientific value. Moreover, even if some readiness potential could be measured, isnt it possible that RP itself is indicative of nothing more than the result of various stimuli, including being placed in a control room, hearing instructions, and focusing on a specific task? In this view, it would be akin to heightened anxiety that a patient might feel prior or during a conventional physical examination.

In addition, the tests performed were narrow in scope and duration. They generally involved very simple motor functions to be undertaken, or not, within seconds of some signal. But Princeton psychologist and Nobel Prize winning economist Daniel Kahneman teaches that we think fast and slow. His core observation is that humans operate with two different thought modes. In the first, known as System 1, the brain operates automatically and quickly, with little or no effort and no sense of voluntary control. In the other, known as System 2, the brain allocates attention to the effortful mental activities that demand it, including complex computations. Kahneman associates the operation of System 2 with what we feel as agency and choice.

Is it possible that a persons brain activity, as recorded by an EEG, an fMRI or some other mode of neuroimaging, would display different results in circumstances where more complex actions are involved, especially over an extended period? Is it conceivable that brain activity would be different if the subjects were in a kitchen and asked to choose how many, if any, eggs they wanted for breakfast, and how they preferred them cooked, and with what bread, what spread and what fruit and drink? And might that kind of brain activity be different still than the kind involved in deciding over the course of a presidential campaign which candidate to support or during courtship deciding whether to select a certain someone for a life partner?

We have no EEGs or other scans that address breakfast or political or marital choices, but some recent experiments suggest that the death of free will, as announced by Jerry Coyne and Sam Harris, may have been not just premature, but unwarranted. In 2012, French neuroscientists published a report in the Proceedings of the National Academy of Sciences concerning a study about RP which included a variation on Libets experiments, specifically an audible cue to the participants to make a movement in response to an unpredictable noise. Rather than reflecting the final causal stages of planning and preparation for movement, Aaron Schurger et al. found that neural activity in the brain fluctuated normally and that decisions about self-initiated movement were at least partially determined by spontaneous fluctuations in such activity. In other words, movement might not be determined subconsciously, but may simply occur when the brain is in a sufficient state of arousal.

Similarly, a study undertaken by graduate student Prescott Alexander and his team attempted to isolate motor and non-motor contributions to RP. As reported in 2016 in Consciousness and Cognition, they found that robust RPs occurred in the absence of movement and that motor-related processes did not significantly modulate the RP. This suggested to Alexander et al. that the RP measured was unlikely to reflect preconscious motor planning or preparation of an ensuing movement, and instead may reflect decision-related or anticipatory processes that are non-motoric in nature. They concluded, in part that RP does not primarily reflect processes unique to motor execution or preparation, and may not even be primarily generated by the neural activity involved in making a free choice.

What does this mean? At a minimum, Schurger and Alexander, and their teams, have interrupted what seemed to be developing scientific support for hard determinism and against free will. They have provided scientific grounding for an alternative understanding of previously accumulative data. In the words of cognitive neuroscientist Anil Seth (speaking of Schuger et al.), they have opened the door towards a richer understanding of the neural basis of the conscious experience of volition.

Consequently, when Alfred Mele argues that science has not disproved free will, he is correct. Science has not falsified the free will hypothesis even once, let alone in the kind of replicable experiment that is the hallmark of the scientific method. At the same time, science has not confirmed the free will hypothesis either. The unsettled state of affairs is not necessarily bad, though, for at least two reasons.

First, the reality is that we are at the early stages of our understanding of both the human brain and levels of consciousness, and we undoubtedly do not even know what we dont know. For instance, in 2015, neuroscientists were acknowledging that no one knew how the human brain was wired and bemoaning the fact that they could not even map a mouses brain, let alone a human one. About a year later, scientists were able to produce a map of the brains cerebral cortex with a new mapping paradigm, but even so, a participating researcher conceded the limitations of the new map. (See map below.)

Similarly, in early March, 2017, researchers led by neurobiologist and physicist Mayank Mehta at UCLA published a report in the journal Science in which they claim that the brain is much more active than previously believed and that neurons are not purely digital devices, as scientists have held for 60 years, but also show large analog fluctuations . . . . If so, according to Mehta, this changes the way we understand how the brain computes information.

The idea of a more powerful, dynamic brain may trigger yet more revisionism concerning free will, as well. Indeed, it is at least conceivable that the reductionists are looking at the picture in the wrong way, zooming in to try to locate and record each signal the brain emits, rather than stepping back for a broader perspective. That is, for all its amazing discoveries and insights, perhaps neuroscience, as commonly practiced today, is too narrow a science. Perhaps there must be some consideration for the possibility that the vast number of neurons and synapses, and their intricate interconnectedness, in conjunction with neural plasticity, yields something greater than the individual cells themselves, even as water is more than its component molecules made of hydrogen and oxygen. Perhaps consciousness is an emergent phenomenon. (See Nelson, The Emergence of God (University Press 2015) at 32-35.) In this view, at a certain level of collective complexity, consciousness emerges. And with it, free will.

From the history of science and technology, we can assume that the pace of our progress will be uneven and the results surprising. Perhaps we will move faster than did our ancestors on the centuries long path from Ptolemy to Copernicus to Hubble (both the man and the telescope). But how much time we will need is not clear. Consider the journey from Wilbur Wrights first step onto a biplane at Kitty Hawk to Neil Armstrongs first step off the lunar module Eagle on the Moon, and whether neuroscience is arguably more complex than rocket science.

Second, another reality is that the stakes in the multi-disciplinary debate between free will advocates and determinists go far beyond the musings of philosophers and the reputations of neuroscientists seeking grants and fame. Should science somehow disprove free will, should it show that we are not just influenced by our genes and our physical and social environment, but that our response to each option available to us is truly compelled rather than chosen, it is not too hard to imagine at least two dystopian results.

In the first case, should it be generally known that humans have no free will, and that conduct is in fact predetermined, significant numbers of individuals might well feel released from whatever tenuous social bonds now attach to them and engage in disruptive behavior. We already have some experimental evidence from psychologists Kathleen Vos and Roy Baumeister that supports the idea that weakening a belief in free will leads to cheating, stealing, aggression, and reduced helping.

A second worrisome situation that might arise concerns potential screening of individuals for genetic or environmental or other predispositions to anti-social behavior. Might individuals found to possess an anti-social gene be incarcerated or subjected to gene therapy to alter or remove the problematic genetic material? If so, it is not too difficult a leap to rounding up groups of people who, by virtue of their color, ethnicity, geographic origin, socio-economic status or other trait likely share having the offending gene. The infamous Nazi medical experiments on Jews, Roma and others provide a chilling example of the depraved capacity of some humans to mistreat the Other, and to do so ostensibly in the interest of science or some asserted greater good. Social historian Yuval Harari has warned recently about the merger of Big Data with Big Brother. It is a warning worth heeding.

In many ways, then, the free will hypothesis is more important than the understanding laid out in Genesis with respect to creation and evolution. We have learned a great deal about how our universe came into existence and how life forms have evolved. And we have learned that we can survive quite well with such knowledge. But if the free will hypothesis is incorrect, if we are only products of our genes and our environment and of the purely mechanical interplay of chemistry and physics, if we do not have any meaningful capacity to make choices, then we could still proceed as if we were free and our decisions mattered (a path advocated by some determinists like Israeli philosopher Saul Smilansky), but there would be a cloud hanging over us, and, worse, we could not dissipate it. We could not overcome.

Yet, even in the most dire circumstances, some do overcome. Recounting the horrors of the concentration camps, psychiatrist and neurologist Viktor Frankl noted that despite the conditions, the actions of some showed that everything can be taken away from a man but one thing: the last of the human freedoms to choose ones attitude in any given set of circumstances, to choose ones own way.

Why some react one way under pressure (or without it) and others do not remains a mystery, as even Sam Harris has acknowledged. Maybe science will solve that mystery some day, but maybe not. So, perhaps Descartes (1596-1650) was not quite right when he declared Cogito, ergo sum, that is, I think, therefore I am. Perhaps thinking is a necessary but not sufficient element of being. Perhaps we need to be able to choose to be fully alive and vital. Consequently, until, if ever, the scientists prove otherwise: Eligo, ergo sum I choose, therefore I am. Or at least I think I do. And at least once every year I am grateful to the Deuteronomist for reminding me of the extensive menu of blessings and curses that is set out before me, and for his emphatic call to choose life.

Go here to see the original:
Judaism, neuroscience and the free will hypothesis (Part 2) - Jewish Journal (blog)

Cow herd behavior is fodder for complex systems analysis – Phys.Org

June 20, 2017 Credit: CC0 Public Domain

The image of grazing cows in a field has long conjured up a romantic nostalgia about a relaxed pace of rural life. With closer inspection, however, researchers have recognized that what appears to be a randomly dispersed herd peacefully eating grass is in fact a complex system of individuals in a group facing differing tensions. A team of mathematicians and a biologist has now built a mathematical model that incorporates a cost function to behavior in such a herd to understand the dynamics of such systems.

Complex systems research looks at how systems display behaviors beyond those capable from individual components in isolation. This rapidly emerging field can be used to elucidate phenomena observed in many other disciplines including biology, medicine, engineering, physics and economics.

"Complex systems science seeks to understand not just the isolated components of a given system, but how the individual components interact to produce 'emergent' group behaviour," said Erik Bollt, director of the Clarkson Center for Complex Systems Science and a professor of mathematics and of electrical and computer engineering.

Bollt conducted the work with his team, lead-authored by post-doctoral fellow Kelum Gajamannage, which was reported this week in the journal Chaos.

"Cows grazing in a herd is an interesting example of a complex system," said Bollt. "An individual cow performs three major activities throughout an ordinary day. It eats, it stands while it carries out some digestive processes, and then it lies down to rest."

While this process seems simple enough, there is also a balancing of group dynamics at work.

"Cows move and eat in herds to protect themselves from predators," said Bollt. "But since they eat at varying speeds, the herd can move on before the slower cows have finished eating. This leaves these smaller cows facing a difficult choice: Continue eating in a smaller, less safe group, or move along hungry with the larger group. If the conflict between feeding and keeping up with a group becomes too large, it may be advantageous for some animals to split into subgroups with similar nutritional needs."

Bollt and his colleagues incorporate a cost function into their model to capture these tensions. This adds mathematical complexity to their work, but it became apparent that it was necessary after discussing cows' behavior with their co-author, Marian Dawkins, a biologist with experience researching cows.

"Some findings from the simulation were surprising," Bollt said. "One might have thought there would be two static groups of cowsthe fast eaters and the slow eatersand that the cows within each group carried out their activities in a synchronized fashion. Instead we found that there were also cows that moved back and forth between the two."

"The primary cause is that this complex system has two competing rhythms," Bollt also said. "The large-sized animal group had a faster rhythm and the small-sized animal group had a slower rhythm. To put it into context, a cow might find itself in one group, and after some time the group is too fast. Then it moves to the slower group, which is too slow, but while moving between the two groups, the cow exposes itself more to the danger of predators, causing a tension between the cow's need to eat and its need for safety."

The existing model and cost function could be used as a basis for studying other herding animals. In the future, there may even be scope to incorporate it into studies about human behavior in groups. "The cost function is a powerful tool to explore outcomes in situations where there are individual and group-level tensions at play," said Bollt.

Explore further: Horses masticate similarly to ruminants

More information: Kelum Gajamannage et al, Modeling the lowest-cost splitting of a herd of cows by optimizing a cost function, Chaos: An Interdisciplinary Journal of Nonlinear Science (2017). DOI: 10.1063/1.4983671

In contrast to ruminants, horses chew their food only oncebut with the same regu-lar, rhythmic movements as cows, who ruminate their food after eating, as demon-strated by researchers at the University of Zurich and the ...

Dairy cows housed indoors want to break curfew and roam free, suggests new research from the University of British Columbia, published today in Scientific Reports.

A group of Clarkson University mathematicians and a civil engineer developed a passive and noninvasive approach to "listen" to a collection of relevant signals from bridges and other mechanical structures to diagnose changes ...

A Fitbit for cows? Collars with tags that carry an accelerometer the same technology used in the popular fitness-tracking device are effective noninvasive tools for tracking the health of dairy cows, according to ...

Animal scientist Phil Cardoso knew that milk protein increases when dairy cows are fed the amino acid methionine, but he suspected that the supplement might have additional health benefits.

Cattle with subacute ruminal acidosis suffer from a number of low-level ailments that affect productivity. A research team led by University of Illinois scientists has documented changes in pH, microbiome, and rumen epithelial ...

You may not have heard of optical coherence tomography, or OCT. But if you've visited an ophthalmologist recently, chances are your eye came within an inch or two of a scanning device employing the technology. Tens of thousands ...

In the last decades, mobile phones and other wireless devices have become central features of life around the globe. These devices radiate varied amounts of electromagnetic energy and thus project electric fields into the ...

The image of grazing cows in a field has long conjured up a romantic nostalgia about a relaxed pace of rural life. With closer inspection, however, researchers have recognized that what appears to be a randomly dispersed ...

Glow sticks, like those brandished by trick-or-treaters and partygoers, light up due to excited electrons of the molecules in the contained fluorescent dye. Electrons accept the exciting energy from a chemical reaction that ...

Ocean circulation patterns have a profound effect on global climate. Waves deep within the ocean play an important role in establishing this circulation, arising when tidal currents oscillate over an uneven ocean bottom. ...

Bursts of plasma, called plasma jets, have numerous uses ranging from the development of more efficient engines, which could one day send spacecraft to Mars, to industrial uses like spraying nanomaterial coatings on 3-D objects.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

See original here:
Cow herd behavior is fodder for complex systems analysis - Phys.Org

Animal Behavior Regulated by Interaction of Tidal, Circadian Clocks – Laboratory Equipment

A slater-like crustacean that lives in the sand on Aucklands Piha beach has provided new evidence that animals have biological clocks influenced by the tide as well as the more familiar circadian clock that follows the day/night cycle and regulates human behavior.

While the molecular mechanism of the circadian clock in humans is well known, including its location in the human brain and the genes involved, the mechanisms of other biological clocks are not.

Many animals are known to have extra biological clocks that regulate feeding or reproduction according to the tide or lunar cycle, but scientists have been unsure of how they work, particularly over longer periods.

Senior lecturer James Cheeseman from the faculty of medical and health sciences, and Mike Walker from the School of Biological Sciences at the University of Auckland carried out a study of Scyphax ornatus, a nocturnal sand-burrowing isopod that feeds on the plant and animal detritus that is moved up the beach by the incoming tide.

Leaving their burrows only at night, the animals need to maximize the amount of time for feeding before the tide comes in. In the wild, they appear able to follow a semilunar or approximately fortnightly feeding cycle, meaning something other than the circadian clock must be regulating their behavior.

Taking the animals from Piha into the laboratory, the study used artificially manipulated light and tidal cycles to test several hypotheses for the mechanism of the semilunar clock that controls their behavior.

The study found the animals followed internal biological clocks even when deprived of external stimuli.

What we have found is that, in the laboratory, with light and tide cycles artificially manipulated, these animals follow the same rules of behavior as they would in the wild, says Cheeseman. So we can very accurately change the semilunar rhythm by changing the perceived length of the day and tidal cycles.

That tells us their semilunar or fortnightly behavior continues to be regulated by the interaction of circatidal and circadian clocks even where there is either no external stimuli or they are in an environment with artificial light cycles or tidal cycles.

Walker said circalunar and circatidal behavior in animals was well known by early Maori who followed a fishing and planting calendar over the circalunar cycle.

The study is published in Scientific Reports.

Go here to read the rest:
Animal Behavior Regulated by Interaction of Tidal, Circadian Clocks - Laboratory Equipment

A Surprising Disappointment Derails NewLink Genetics — What’s … – Motley Fool

Roche Holdings(NASDAQOTH:RHHBY)surprisinglycut ties with NewLink Genetics (NASDAQ:NLNK)on GDC-0919 last week, and that decision puts NewLink Genetics further back behindIncyte Corporationin theraceto develop a new class of cancer-fighting drugs called IDO inhibitors.

Roche Holdings' decision is particularly disappointing because industry watchers had thought GDC-0919 would be NewLink Genetics most competitive IDO-ihibitor. Now that GDC-0919's future is in flux,investors are right to wonder what's up next for NewLink Genetics.

Indoleamine 2,3-dioxygenase (IDO) is a protein that has immunosuppressive effects, and because cancer cells can hijack it to evade detection by the immune system, drug developers think inhibiting its activity could help other cancer medications work better.

IMAGE SOURCE: GETTY IMAGES.

At the forefront of this research are NewLink Genetics and Incyte. Until now, NewLink Genetics has been developing indoximod and GDC-0919, while Incyte Corporation has been developing epacadostat.

In April,NewLink Genetics reported that the objective response rate in a 60-person phase 2 study evaluating indoximod alongside Merck & Co.'s (NYSE:MRK) Keytruda in advanced melanoma was 52%. If you include patients with stable disease, the rate increases to 72%.

Similarly, Incyte Corporation reported data from its own melanoma trial earlier this year showing patient's objective response rate to epacadostat plus Keytruda was 58%. A total of 74% had a complete response, partial response, or stable disease.

In both cases, the findings suggest each of these drugs could win FDA approval someday. Especially since theFDA approved Keytruda for use as a monotherapy in advanced melanoma patients after it delivered a 33% objective response rate.

However, it's Incyte's drug that's closer to FDA review, and that first-mover advantage, plus the similarity in results from these trials,could make it difficult for indoximod to win away market share.

Because of Incyte's lead over indoximod, industry watchers' had hoped trials evaluating GDC-0919 wouldshow it works better than epacadostat in cancers other than melanoma.Unfortunately, that doesn't appear to be the case. Last week, Roche presented data onGDC-0919 at the American Society of Clinical Oncology (ASCO) conference that was lackluster, and it appears those results were a big reason why Roche has decided to walk away from developing it any further.

Specifically, adding GDC-0919 to Roche's Tecentriq (a drug that works similarly to Keytruda) resulted in anobjective response rate of just 9% across a variety of cancers. For comparison, adding epacadostat to Keytruda resulted in objective response rates of between 30% to 35% in a variety of cancers, including non-small cell lung cancer.

NewLink Genetics hasn't licensed indoximod to anyone yet, and now that it's getting the rights to GDC-0919 back, it's got a decision to make. Developing both of these drugs concurrently would be costly, and the company probably can't afford it.

As of March 31, it has $118 million in cash on its books, but it's burning through that cash at a rate of $12 million per quarter. Cash burn is likely to increase from here given plans to start a registration ready trial of indoximod in melanoma this year. Currently, management expects it will finish 2017 with $75 million in cash, and that suggests to me that a cash crunch could be coming in 2018.

Ideally, NewLink Genetics probably wants to convince another company to share in development costs by out-licensing GDC-0919 again. However, that seems less likely given Roche's data at ASCO.

It's also possible thatNewLink Genetics would consider selling itself lock, stock, and barrel. However, finding a buyer could be unlikely too. The most logical suitors would be companies marketing PD-1 checkpoint inhibitors that they could pair up with NewLink Genetics drugs, but the two leaders in this class areBristol-Myers Squibb and Merck & Co., and they're already working with Incyte.

If licensing and M&A is off the table, then NewLink Genetics next option could be tapping equity investors for more money. However,that's not going to be easy given its crumbling share price.

NLNK data by YCharts

In the end, NewLink Genetics might have to focus on indoximod trials and hold-off on developing GDC-0919 -- at least until new data emerges that reignites its share price.

Potentially, trials evaluatingindoximod plus Abraxane and gemcitabine in pancreatic cancer could make that happen. Data from aphase 1/2 trial evaluating indoximod alongside these treatments are expected soon. Fortunately, the bar for success is set pretty low. The ojective response rate for Abraxane plus gemcitabine alone is only 23% in trials, and an interim look at adding indoximod to these drugs produced an objective response rate of 45%.

Having said that, investors might want to keep their optimism in check. Pancreatic cancer is notoriously hard to treat, and there's no guarantee that interim trial results will be confirmed.

Overall,the risks facing NewLink Genetics are big, and the stakes for its survival are higher now than they were before Roche's decision. Therefore, investors should approach this company with a big dose of caution, at least until we know for sure if indoximod's pancreatic cancer trial is a success.

Todd Campbell has no position in any stocks mentioned. His clients may have positions in the companies mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Excerpt from:
A Surprising Disappointment Derails NewLink Genetics -- What's ... - Motley Fool

Is coffee your friend or foe? Genetics makes a difference – Seattle Times

More than half of American adults drink coffee daily. But how does that caffeine affect us, biologically? It depends on genetics.

Is morning just not morning without a steaming mug of coffee in your hand? Youre not alone, as a little more than half of American adults drink coffee daily, for the taste, the aroma, the pick-me-up or all of the above. I suspect that numbers even higher in Seattle. As an added bonus, moderate coffee consumption is linked to a number of health benefits, including reduced risk of developing type 2 diabetes. But for some people, the caffeine in even moderate amounts of coffee could have a downside.

The safe caffeine limit for healthy nonpregnant adults is 400 milligrams (mg) per day, the amount in four average 8-ounce cups of brewed coffee. The average caffeine intake in this country is about 180 mg per day, but those averages are just that average. Some people get less caffeine than that, and others get more, sometimes much more, because not all coffee is average.

For example, a 12-ounce medium roast at Starbucks has about 235 mg. Get a refill and youve exceeded your limit. Then theres the growing trend of super-high-octane coffee, with brands like Black Insomnia and Death Wish competing for the title of worlds strongest coffee and clocking in at about 700 mg of caffeine for a 12-ounce cup. While thats not optimal for anyone, for some people it might be risky the collision of genetic differences in how we metabolize caffeine with the latest generation of high-caffeine beverages may have unintended consequences.

How caffeine makes you feel is partly due to your tolerance level, but its largely due to genetics. Of greatest concern is one gene CYP1A2 that alters how caffeine affects us, but in ways we dont actually feel. Depending on which version of the CYP1A2 gene you inherited, you metabolize (break down) caffeine slow or fast. Lets look at why that matters.

For a long time, drinking more than a few cups of coffee was linked to an increased risk of heart attack. But when researchers looked closer several years ago, they found that risk was only increased among people who were slow caffeine metabolizers. For slow metabolizers, one cup per day wasnt a problem, but after that, the risk started to rise. Slow metabolizers under the age of 50 who drink four cups per day or more had quadruple the risk of having a heart attack. By contrast, fast metabolizers especially those under age 59 actually saw reduced risk of heart attack with a moderate one to three cups per day.

Four cups of coffee for one person might be the biological equivalent of one cup for someone else, just depending on how much of that caffeine sticks around in their system, said Ahmed El-Sohemy, PhD, one of the studys authors, at the 2017 Nutrition & Health conference in Phoenix in May. He said more recent studies have found similar effects for risk of pre-diabetes, hypertension and kidney disease in slow metabolizers.

El-Sohemy said that slow metabolizers dont self-regulate caffeine because they dont feel the difference. So what does this mean for you? You could get tested for the CYP1A2 gene, but insurance might not cover it. Or, you could play it safe and enjoy a moderately sized cup or two and leave it at that. You could go decaf or half-caf decaffeinated coffee contains the same health-promoting compounds, including phytonutrients, found in regular coffee. Finally, if you find you rely on coffee to get through the day, maybe its time to cultivate a more beneficial source of energy sleep!

Go here to see the original:
Is coffee your friend or foe? Genetics makes a difference - Seattle Times

Seattle Genetics ends clinical trial of leukemia drug after ‘a higher rate of deaths’ – The Seattle Times

Seattle Genetics said it is discontinuing a Phase 3 clinical trial after data showed a higher rate of deaths, including fatal infections in acute myeloid leukemia patients receiving its drug than in the studys other patients.

By Seattle Times business staff

Seattle Genetics said it is discontinuing a Phase 3 clinical trial after data showed a higher rate of deaths, including fatal infections in acute myeloid leukemia (AML) patients receiving its drug than in the studys other patients.

As a result of data it received June 16, the company said Monday, Seattle Genetics is suspending patient enrollment and treatment in all of its clinical trials on the drug, called vadastuximab talirine or SGN-CD33A. The drug was also being used in a Phase 1/2 clinical trial in myelodysplastic syndrome (MDS).

Both studies were testing the drug as a so-called front-line treatment, meaning it would be an early therapy rather than a second or third choice for patients who dont respond to initial treatment. It is pursuing similar studies in various cancers for its leading approved drug, Adcetris.

The Bothell-based company did not disclose the number of patient deaths or other details in its statement early Monday. It said it will review the data and consult with the federal Food and Drug Administration (FDA) to determine future plans for the drugs development program.

Three early-stage studies SGN-CD33A in AML patients receiving stem-cell transplants were placed on a clinical hold by the FDA in December, after what the company reported were four fatal events, but the hold was lifted in March. The study discontinued Monday was already in progress at that time.

Seattle Genetics said in December that more than 300 patients had been treated with SGN-CD33A in various clinical trials.

The Phase 3 trial discontinued Monday was a double-blind study of SGN-CD33A in combination with either of two hypomethylating agents, compared with those agents alone, in older patients with newly diagnosed AML.

Seattle Genetics has spent more than $100 million over the past five years on developing the drug, making it the companys second most expensive development program after Adcetris, it said in a regulatory filing last month.

This is a disappointing and unexpected result, said Clay Siegall, president and chief executive officer at Seattle Genetics. Patient safety is our highest priority, and we will closely review the data and evaluate next steps. AML is a devastating disease with a poor prognosis in most patients, and there is a great need for therapeutics against this disease.

Shares of Seattle Genetics opened the day down 8 percent but recovered somewhat, closing at $61.88, down $2.64 or 4.1 percent.

Excerpt from:
Seattle Genetics ends clinical trial of leukemia drug after 'a higher rate of deaths' - The Seattle Times

Apple, PerkinElmer rise; EQT, Seattle Genetics fall – Seattle Times

NEW YORK (AP) Stocks that moved substantially or traded heavily Monday:

PerkinElmer Inc., up $4.16 to $67.73

The company, which sells testing equipment and scientific instruments, agreed to buy Euroimmun Medical Laboratory Diagnostics of Germany.

EQT Corp., down $5.26 to $53.51

The energy company agreed to buy Rice Energy for $6.7 billion in cash and stock.

Novodaq Technologies Inc., up $5.70 to $11.70

The maker of surgical technology is being acquired by Stryker Corp.

Valeant Pharmaceuticals International Inc., up 81 cents to $13.47

The company said hedge-fund manager John Paulson, its largest shareholder, will join the companys board.

U.S. Steel Corp., up 64 cents to $20.80

The Wall Street Journal reported that President Donald Trump may announce plans to curb steel imports.

Apple Inc., up $4.07 to $146.34

Technology companies posted some of the biggest gains in the market.

Hain Celestial Group Inc., down 67 cents to $33.24

The Wall Street Journal reported that the organic food company, which hasnt released financial results for more than a year, risks being delisted from the Nasdaq.

Seattle Genetics Inc., down $2.64 to $61.88

The biotechnology company discontinued a clinical trial of vadastuximab talirine in older acute myeloid leukemia patients.

Read the original:
Apple, PerkinElmer rise; EQT, Seattle Genetics fall - Seattle Times

Mrs May and her gay-hating mates – The New European

PUBLISHED: 13:25 20 June 2017

Mathew Hulbert

DUP leader Arlene Foster and DUP deputy leader Nigel Dodds

PA Wire/PA Images

Email this article to a friend

To send a link to this page you must be logged in.

It comes to a sorry pass when a Government which claims to be all about one nation Conservatism, about being there for every citizen, no matter what their gender identity, race, religion, sexuality or culture, is being propped up by arguably he most extreme political party in the House of Commons today.

The Democratic Unionist Party (DUP) hold views which many would have been seen as old fashioned in the 19th Century, never mind the 21st.

Lots of words have already been broadcast and written about the DUPs socially-conservative view of social issues, especially in regards to LGBT matters.

But, what actually is their record? Lets go back to the partys beginnings in the 1970s, when it was founded by the late Reverend Ian Paisley, who would later go on to be Northern Irelands First Minister:

In 1977 he launched a campaign entitled Save Ulster from Sodomy in the hope of ensuring homosexuality remained illegal in the province;

In 1988 DUP MPs voted against the lowering of the age of consent for gay sex from 18 to 16;

In 2001 DUP MPs voted against a motion to bring forward a gender neutral Civil Registration Bill;

In 2002 DUP MPs voted against an amendment to a Bill to allow unmarried straight and gay couples to adopt children;

In 2004, as well as voting against both the second and third reading of the Gender Recognition Bill, DUP MPs voted against the second and third reading of the Civil Partnerships Bill;

In 2007, party grandee Lord Morrow proposed a motion, in the House of Lords, to defeat the Equality Act (Sexual Orientation) Regulations (Northern Ireland).

Also in 2007, DUP MPs voted against a Government bill to prohibit discrimination on the basis of sexual orientation;

In 2008, DUP peers voted to prevent a clause demanding the need for a father from being removed in the Human Fertilisation and Embryology Bill. If theyd have had their way and the clause had stayed, it would have meant lesbian couples being unable to access IVF treatment;

Again in 2008, DUP MPs twice voted against Government proposals to allow single mothers and lesbian couples to access IVF treatment;

In 2012, 2013, 2014 and 2015 DUP MLAs (Members of the Legislative Assembly) blocked motions aiming to secure same sex marriage in Northern Ireland, using a mechanism called the petition of concern (part of the Good Friday Agreement);

I have chosen not to list the quotes of various DUP elected representatives down the years, who have spoken in vitriolic terms about LGBT people, because theyre that upsetting I dont want to repeat them here and cause my fellow LGBT people any further distress.

But just some of the words used include describing homosexual relationships as immoral, offensive, an abomination and being repulsed by them.

I hope, by now, youre starting to get a good understanding-if you didnt already-of the kind of people who are now holding the Government of this country by the balls.

I know the Tories claims that these, Id argue, appalling views will have no bearing on LGBT rights in the rest of the UK.

But, even if they dont, what kind of message does them being so close to power send out?

What does it say to LGBT young people, who are already often facing bullying and discrimination at home and at school?

What does it say to LGBT people in many nations around the world, where to be gay is to be under threat of persecution and even death?

And, what does it say to LGBT people in Northern Ireland, who deserve to be equal under the law, but are currently treated as second class citizens because any effort to change the laws there are blocked by the DUP?

People are entitled to their own personal beliefs and religious convictions, as a liberal Ill always defend that.

But what theyre not or should not be entitled to do is to use those beliefs, in public policy terms, to block the equality and human rights of others.

That the Conservatives have had to prostrate themselves before the DUP, shows just how low theyll go to retain their grubby grip on power.

We who care about the rights of all LGBT people everywhere must speak up and out against this dangerous Coalition of Chaos.

Mathew Hulbert is an LGBT Rights activist and a former Lib Dem Councillor in Leicestershire. He tweets at @HulbertMathew.

More here:
Mrs May and her gay-hating mates - The New European